Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 8.13 is 59% below its 5-year average of 19.82, near the low end of its 5-year range (3.18–51.16).
As of the fiscal period ended Tuesday, June 30, 2026. 31.86% below its 12-month average of 11.93.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 8.13.
CURRENT RATIO
8.13
CURRENT RATIO AVG TTM
11.93
CURRENT RATIO AVG 3Y
15.85
CURRENT RATIO AVG 5Y
19.82
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-31.86%
CURRENT VS 3Y AVG
-48.70%
CURRENT VS 5Y AVG
-58.98%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.76
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
+116.24%
vs the sector median at left
Atea Pharmaceuticals, Inc.
Market Cap
$405.74M
Current Ratio
8.13
TTM Avg
11.93
3Y Avg
15.85
5Y Avg
19.82
Market Cap
$406.58M
Current Ratio
9.89
TTM Avg
6.34
3Y Avg
6.34
5Y Avg
6.34
Market Cap
$411.00M
Current Ratio
2.64
TTM Avg
6.72
3Y Avg
6.86
5Y Avg
10.11
Market Cap
$411.21M
Current Ratio
16.52
TTM Avg
13.61
3Y Avg
8.86
5Y Avg
8.86
Market Cap
$396.93M
Current Ratio
10.71
TTM Avg
7.83
3Y Avg
8.94
5Y Avg
8.94
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Atea Pharmaceuticals, Inc. (AVIR) | $405.74M | 8.13 | 11.93 | 15.85 | 19.82 |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $406.58M | 9.89 | 6.34 | 6.34 | 6.34 |
| Myriad Genetics, Inc. (MYGN)vs › | $404.24M | 2.21 | 2.16 | 2.08 | 2.23 |
| Neurogene Inc. (NGNE)vs › | $402.17M | 10.64 | 18.70 | 14.71 | 15.05 |
| Strata Critical Medical, Inc. (SRTA)vs › | $411.00M | 2.64 | 6.72 | 6.86 | 10.11 |
| MapLight Therapeutics, Inc. (MPLT)vs › | $411.21M | 16.52 | 13.61 | 8.86 | 8.86 |
| Carlsmed, Inc. (CARL)vs › | $397.99M | 8.84 | 7.23 | 5.35 | 5.35 |
| Shoulder Innovations, Inc. (SI)vs › | $396.93M | 10.71 | 7.83 | 8.94 | 8.94 |
| Rezolute, Inc. (RZLT)vs › | $415.98M | 9.44 | 11.90 | 14.34 | 23.42 |
| Senseonics Holdings, Inc. (SENS)vs › | $416.27M | 6.74 | 3.59 | 4.96 | 4.92 |
Current Ratio
8.13
Quick Ratio
8.13
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 8.13 |
| 2026-03-31 | 7.89 |
| 2025-12-31 | 7.82 |
| 2025-09-30 | 16.66 |
| 2025-06-30 | 19.17 |
| 2025-03-31 | 19.94 |
| 2024-12-31 | 24.85 |
| 2024-09-30 | 19.33 |
| 2024-06-30 | 19.02 |
| 2024-03-31 | 13.28 |
| 2023-12-31 | 18.24 |
| 2023-09-30 | 31.93 |
| 2023-06-30 | 38.42 |
| 2023-03-31 | 51.16 |
| 2022-12-31 | 35.77 |
| 2022-09-30 | 43.62 |
| 2022-06-30 | 27.46 |
| 2022-03-31 | 24.93 |
| 2021-12-31 | 13.58 |
| 2021-09-30 | 3.22 |
| 2021-06-30 | 3.18 |
| 2021-03-31 | 3.30 |
| 2020-12-31 | 2.73 |
| 2020-09-30 | 10.02 |
| 2020-06-30 | 16.78 |
| 2020-03-31 | 9.13 |
| 2019-12-31 | 9.00 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
